Crossmark

An open-label pilot study of oral vitamin C as an opioid-sparing agent in patients with chronic pain secondary to cancer

Crossref DOI link: https://doi.org/10.1007/s00520-016-3472-z

Published Online: 2016-11-04

Published Print: 2017-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Pinkerton, E

Good, P

Gibbons, K

Hardy, J https://orcid.org/0000-0003-1127-9951
Funding

Funding for this research was provided by:

Mater Palliative and Supportive Care Research Fund

Mater Research seeding grant (none)
License Information

License valid from 2016-11-04